HEADER VIRAL PROTEIN 23-MAR-21 7EFR TITLE STRUCTURE OF SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN IN COMPLEX WITH TITLE 2 HIGH AFFINITY ACE2 MUTANT (T27W,N330Y) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROCESSED ANGIOTENSIN-CONVERTING ENZYME 2; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: SPIKE GLYCOPROTEIN; COMPND 7 CHAIN: B; COMPND 8 FRAGMENT: UNP RESIDUES 321-537; COMPND 9 SYNONYM: S GLYCOPROTEIN,E2,PEPLOMER PROTEIN; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACE2, UNQ868/PRO1885; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 10 2; SOURCE 11 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 12 ORGANISM_TAXID: 2697049; SOURCE 13 GENE: S, 2; SOURCE 14 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS RECEPTOR-BINDING DOMAIN, ANGIOTENSIN CONVERTING ENZYME 2, VIRAL KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR G.W.LU,F.YE,X.LIN REVDAT 2 29-NOV-23 7EFR 1 REMARK REVDAT 1 24-NOV-21 7EFR 0 JRNL AUTH F.YE,X.LIN,Z.CHEN,F.YANG,S.LIN,J.YANG,H.CHEN,H.SUN,L.WANG, JRNL AUTH 2 A.WEN,X.ZHANG,Y.DAI,Y.CAO,J.YANG,G.SHEN,L.YANG,J.LI,Z.WANG, JRNL AUTH 3 W.WANG,X.WEI,G.LU JRNL TITL S19W, T27W, AND N330Y MUTATIONS IN ACE2 ENHANCE SARS-COV-2 JRNL TITL 2 S-RBD BINDING TOWARD BOTH WILD-TYPE AND ANTIBODY-RESISTANT JRNL TITL 3 VIRUSES AND ITS MOLECULAR BASIS. JRNL REF SIGNAL TRANSDUCT TARGET THER V. 6 343 2021 JRNL REFN ESSN 2059-3635 JRNL PMID 34531369 JRNL DOI 10.1038/S41392-021-00756-4 REMARK 2 REMARK 2 RESOLUTION. 2.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.28 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 53980 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2698 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 26.2840 - 6.6212 0.98 2872 144 0.1737 0.1876 REMARK 3 2 6.6212 - 5.2693 1.00 2795 149 0.1901 0.2147 REMARK 3 3 5.2693 - 4.6073 1.00 2766 139 0.1586 0.1834 REMARK 3 4 4.6073 - 4.1879 1.00 2736 137 0.1461 0.1824 REMARK 3 5 4.1879 - 3.8887 1.00 2716 142 0.1602 0.1952 REMARK 3 6 3.8887 - 3.6601 1.00 2699 143 0.1848 0.2253 REMARK 3 7 3.6601 - 3.4772 1.00 2704 141 0.1947 0.2246 REMARK 3 8 3.4772 - 3.3262 1.00 2665 155 0.2010 0.2583 REMARK 3 9 3.3262 - 3.1983 1.00 2719 121 0.2351 0.2952 REMARK 3 10 3.1983 - 3.0882 1.00 2696 136 0.2316 0.3102 REMARK 3 11 3.0882 - 2.9917 1.00 2635 175 0.2115 0.2549 REMARK 3 12 2.9917 - 2.9063 1.00 2656 149 0.2210 0.2958 REMARK 3 13 2.9063 - 2.8299 1.00 2675 155 0.2188 0.2561 REMARK 3 14 2.8299 - 2.7609 1.00 2683 134 0.2320 0.2886 REMARK 3 15 2.7609 - 2.6982 1.00 2690 130 0.2238 0.3342 REMARK 3 16 2.6982 - 2.6409 1.00 2686 135 0.2245 0.2385 REMARK 3 17 2.6409 - 2.5881 1.00 2639 140 0.2342 0.2590 REMARK 3 18 2.5881 - 2.5393 1.00 2657 139 0.2383 0.2975 REMARK 3 19 2.5393 - 2.4940 0.97 2593 134 0.2515 0.2855 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.630 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.56 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 16.1108 34.3238 38.7118 REMARK 3 T TENSOR REMARK 3 T11: 0.3982 T22: 0.4523 REMARK 3 T33: 0.4132 T12: 0.0254 REMARK 3 T13: 0.0060 T23: 0.1262 REMARK 3 L TENSOR REMARK 3 L11: 1.5050 L22: 0.1399 REMARK 3 L33: 0.3944 L12: 0.1905 REMARK 3 L13: -0.7059 L23: -0.0801 REMARK 3 S TENSOR REMARK 3 S11: -0.0284 S12: -0.1390 S13: 0.0133 REMARK 3 S21: 0.0880 S22: -0.0285 S23: -0.0194 REMARK 3 S31: 0.0260 S32: 0.1846 S33: 0.0570 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7EFR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 23-MAR-21. REMARK 100 THE DEPOSITION ID IS D_1300021379. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUL-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL18U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97915 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 54217 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.490 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 21.00 REMARK 200 R MERGE (I) : 0.12600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.17300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 6LZG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.0 M AMMONIUM SULFATE, 0.1 M SODIUM REMARK 280 HEPES PH7.5 , 2 % V/V PEG 400, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.03100 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 69.78900 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 69.78900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 117.04650 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 69.78900 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 69.78900 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 39.01550 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 69.78900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 69.78900 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 117.04650 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 69.78900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 69.78900 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 39.01550 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 78.03100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32910 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 17 REMARK 465 ASP A 18 REMARK 465 ASP A 615 REMARK 465 GLN B 321 REMARK 465 PRO B 322 REMARK 465 THR B 323 REMARK 465 GLU B 324 REMARK 465 SER B 325 REMARK 465 ILE B 326 REMARK 465 VAL B 327 REMARK 465 ARG B 328 REMARK 465 PHE B 329 REMARK 465 PRO B 330 REMARK 465 ASN B 331 REMARK 465 ILE B 332 REMARK 465 THR B 333 REMARK 465 LYS B 528 REMARK 465 LYS B 529 REMARK 465 SER B 530 REMARK 465 THR B 531 REMARK 465 ASN B 532 REMARK 465 LEU B 533 REMARK 465 VAL B 534 REMARK 465 LYS B 535 REMARK 465 ASN B 536 REMARK 465 LYS B 537 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 374 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 378 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 402 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN A 81 C6 NAG A 1003 1.69 REMARK 500 CG ASN A 103 C1 NAG A 1003 1.86 REMARK 500 OD1 ASN A 103 C1 NAG A 1003 1.92 REMARK 500 O HOH B 731 O HOH B 732 2.10 REMARK 500 ND2 ASN A 103 C2 NAG A 1003 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS B 488 CB CYS B 488 SG -0.098 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 133 CA - CB - SG ANGL. DEV. = -16.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 53 74.48 -157.54 REMARK 500 SER A 254 -12.77 91.27 REMARK 500 ASP A 494 158.52 -36.15 REMARK 500 ALA B 352 51.71 -119.07 REMARK 500 ALA B 372 -169.85 -165.93 REMARK 500 PHE B 377 85.13 -151.59 REMARK 500 ASN B 422 -54.80 -124.31 REMARK 500 ASP B 428 30.73 -91.88 REMARK 500 CYS B 480 -159.24 -89.82 REMARK 500 ASN B 481 52.39 -163.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 CYS B 480 ASN B 481 -147.10 REMARK 500 REMARK 500 REMARK: NULL DBREF 7EFR A 19 615 UNP Q9BYF1 ACE2_HUMAN 19 615 DBREF 7EFR B 321 537 UNP P0DTC2 SPIKE_SARS2 321 537 SEQADV 7EFR ALA A 17 UNP Q9BYF1 EXPRESSION TAG SEQADV 7EFR ASP A 18 UNP Q9BYF1 EXPRESSION TAG SEQADV 7EFR TRP A 27 UNP Q9BYF1 THR 27 ENGINEERED MUTATION SEQADV 7EFR TYR A 330 UNP Q9BYF1 ASN 330 ENGINEERED MUTATION SEQRES 1 A 599 ALA ASP SER THR ILE GLU GLU GLN ALA LYS TRP PHE LEU SEQRES 2 A 599 ASP LYS PHE ASN HIS GLU ALA GLU ASP LEU PHE TYR GLN SEQRES 3 A 599 SER SER LEU ALA SER TRP ASN TYR ASN THR ASN ILE THR SEQRES 4 A 599 GLU GLU ASN VAL GLN ASN MET ASN ASN ALA GLY ASP LYS SEQRES 5 A 599 TRP SER ALA PHE LEU LYS GLU GLN SER THR LEU ALA GLN SEQRES 6 A 599 MET TYR PRO LEU GLN GLU ILE GLN ASN LEU THR VAL LYS SEQRES 7 A 599 LEU GLN LEU GLN ALA LEU GLN GLN ASN GLY SER SER VAL SEQRES 8 A 599 LEU SER GLU ASP LYS SER LYS ARG LEU ASN THR ILE LEU SEQRES 9 A 599 ASN THR MET SER THR ILE TYR SER THR GLY LYS VAL CYS SEQRES 10 A 599 ASN PRO ASP ASN PRO GLN GLU CYS LEU LEU LEU GLU PRO SEQRES 11 A 599 GLY LEU ASN GLU ILE MET ALA ASN SER LEU ASP TYR ASN SEQRES 12 A 599 GLU ARG LEU TRP ALA TRP GLU SER TRP ARG SER GLU VAL SEQRES 13 A 599 GLY LYS GLN LEU ARG PRO LEU TYR GLU GLU TYR VAL VAL SEQRES 14 A 599 LEU LYS ASN GLU MET ALA ARG ALA ASN HIS TYR GLU ASP SEQRES 15 A 599 TYR GLY ASP TYR TRP ARG GLY ASP TYR GLU VAL ASN GLY SEQRES 16 A 599 VAL ASP GLY TYR ASP TYR SER ARG GLY GLN LEU ILE GLU SEQRES 17 A 599 ASP VAL GLU HIS THR PHE GLU GLU ILE LYS PRO LEU TYR SEQRES 18 A 599 GLU HIS LEU HIS ALA TYR VAL ARG ALA LYS LEU MET ASN SEQRES 19 A 599 ALA TYR PRO SER TYR ILE SER PRO ILE GLY CYS LEU PRO SEQRES 20 A 599 ALA HIS LEU LEU GLY ASP MET TRP GLY ARG PHE TRP THR SEQRES 21 A 599 ASN LEU TYR SER LEU THR VAL PRO PHE GLY GLN LYS PRO SEQRES 22 A 599 ASN ILE ASP VAL THR ASP ALA MET VAL ASP GLN ALA TRP SEQRES 23 A 599 ASP ALA GLN ARG ILE PHE LYS GLU ALA GLU LYS PHE PHE SEQRES 24 A 599 VAL SER VAL GLY LEU PRO ASN MET THR GLN GLY PHE TRP SEQRES 25 A 599 GLU TYR SER MET LEU THR ASP PRO GLY ASN VAL GLN LYS SEQRES 26 A 599 ALA VAL CYS HIS PRO THR ALA TRP ASP LEU GLY LYS GLY SEQRES 27 A 599 ASP PHE ARG ILE LEU MET CYS THR LYS VAL THR MET ASP SEQRES 28 A 599 ASP PHE LEU THR ALA HIS HIS GLU MET GLY HIS ILE GLN SEQRES 29 A 599 TYR ASP MET ALA TYR ALA ALA GLN PRO PHE LEU LEU ARG SEQRES 30 A 599 ASN GLY ALA ASN GLU GLY PHE HIS GLU ALA VAL GLY GLU SEQRES 31 A 599 ILE MET SER LEU SER ALA ALA THR PRO LYS HIS LEU LYS SEQRES 32 A 599 SER ILE GLY LEU LEU SER PRO ASP PHE GLN GLU ASP ASN SEQRES 33 A 599 GLU THR GLU ILE ASN PHE LEU LEU LYS GLN ALA LEU THR SEQRES 34 A 599 ILE VAL GLY THR LEU PRO PHE THR TYR MET LEU GLU LYS SEQRES 35 A 599 TRP ARG TRP MET VAL PHE LYS GLY GLU ILE PRO LYS ASP SEQRES 36 A 599 GLN TRP MET LYS LYS TRP TRP GLU MET LYS ARG GLU ILE SEQRES 37 A 599 VAL GLY VAL VAL GLU PRO VAL PRO HIS ASP GLU THR TYR SEQRES 38 A 599 CYS ASP PRO ALA SER LEU PHE HIS VAL SER ASN ASP TYR SEQRES 39 A 599 SER PHE ILE ARG TYR TYR THR ARG THR LEU TYR GLN PHE SEQRES 40 A 599 GLN PHE GLN GLU ALA LEU CYS GLN ALA ALA LYS HIS GLU SEQRES 41 A 599 GLY PRO LEU HIS LYS CYS ASP ILE SER ASN SER THR GLU SEQRES 42 A 599 ALA GLY GLN LYS LEU PHE ASN MET LEU ARG LEU GLY LYS SEQRES 43 A 599 SER GLU PRO TRP THR LEU ALA LEU GLU ASN VAL VAL GLY SEQRES 44 A 599 ALA LYS ASN MET ASN VAL ARG PRO LEU LEU ASN TYR PHE SEQRES 45 A 599 GLU PRO LEU PHE THR TRP LEU LYS ASP GLN ASN LYS ASN SEQRES 46 A 599 SER PHE VAL GLY TRP SER THR ASP TRP SER PRO TYR ALA SEQRES 47 A 599 ASP SEQRES 1 B 217 GLN PRO THR GLU SER ILE VAL ARG PHE PRO ASN ILE THR SEQRES 2 B 217 ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR ARG SEQRES 3 B 217 PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SER SEQRES 4 B 217 ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER ALA SEQRES 5 B 217 SER PHE SER THR PHE LYS CYS TYR GLY VAL SER PRO THR SEQRES 6 B 217 LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA ASP SEQRES 7 B 217 SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE ALA SEQRES 8 B 217 PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN TYR LYS SEQRES 9 B 217 LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP ASN SEQRES 10 B 217 SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN TYR ASN SEQRES 11 B 217 TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU LYS PRO SEQRES 12 B 217 PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA GLY SEQRES 13 B 217 SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN CYS TYR SEQRES 14 B 217 PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR ASN GLY SEQRES 15 B 217 VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER PHE SEQRES 16 B 217 GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY PRO LYS SEQRES 17 B 217 LYS SER THR ASN LEU VAL LYS ASN LYS HET NAG A1001 14 HET NAG A1002 14 HET NAG A1003 14 HET NAG A1004 14 HET NAG B 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 5(C8 H15 N O6) FORMUL 8 HOH *144(H2 O) HELIX 1 AA1 THR A 20 ASN A 53 1 34 HELIX 2 AA2 THR A 55 GLN A 81 1 27 HELIX 3 AA3 MET A 82 TYR A 83 5 2 HELIX 4 AA4 PRO A 84 ILE A 88 5 5 HELIX 5 AA5 ASN A 90 ALA A 99 1 10 HELIX 6 AA6 GLY A 104 LEU A 108 5 5 HELIX 7 AA7 SER A 109 GLY A 130 1 22 HELIX 8 AA8 PRO A 146 SER A 155 1 10 HELIX 9 AA9 ASP A 157 VAL A 172 1 16 HELIX 10 AB1 VAL A 172 ASN A 194 1 23 HELIX 11 AB2 ASP A 198 GLY A 205 1 8 HELIX 12 AB3 ASP A 206 GLU A 208 5 3 HELIX 13 AB4 SER A 218 TYR A 252 1 35 HELIX 14 AB5 TRP A 275 ASN A 277 5 3 HELIX 15 AB6 LEU A 278 VAL A 283 1 6 HELIX 16 AB7 VAL A 293 GLN A 300 1 8 HELIX 17 AB8 ASP A 303 VAL A 318 1 16 HELIX 18 AB9 THR A 324 SER A 331 1 8 HELIX 19 AC1 THR A 365 TYR A 385 1 21 HELIX 20 AC2 PRO A 389 ARG A 393 5 5 HELIX 21 AC3 ASN A 397 ALA A 413 1 17 HELIX 22 AC4 THR A 414 ILE A 421 1 8 HELIX 23 AC5 ASP A 431 VAL A 447 1 17 HELIX 24 AC6 GLY A 448 LYS A 465 1 18 HELIX 25 AC7 PRO A 469 ASP A 471 5 3 HELIX 26 AC8 GLN A 472 ILE A 484 1 13 HELIX 27 AC9 CYS A 498 SER A 502 5 5 HELIX 28 AD1 LEU A 503 ASN A 508 1 6 HELIX 29 AD2 ILE A 513 ALA A 533 1 21 HELIX 30 AD3 PRO A 538 CYS A 542 5 5 HELIX 31 AD4 SER A 547 ARG A 559 1 13 HELIX 32 AD5 PRO A 565 GLY A 575 1 11 HELIX 33 AD6 VAL A 581 ASN A 599 1 19 HELIX 34 AD7 LYS A 600 SER A 602 5 3 HELIX 35 AD8 PRO B 337 ASN B 343 1 7 HELIX 36 AD9 SER B 349 TRP B 353 5 5 HELIX 37 AE1 ASP B 364 ASN B 370 1 7 HELIX 38 AE2 SER B 383 ASN B 388 1 6 HELIX 39 AE3 ASP B 405 ILE B 410 5 6 HELIX 40 AE4 GLY B 416 ASN B 422 1 7 HELIX 41 AE5 SER B 438 SER B 443 1 6 HELIX 42 AE6 GLY B 502 TYR B 505 5 4 SHEET 1 AA1 2 LYS A 131 CYS A 133 0 SHEET 2 AA1 2 CYS A 141 LEU A 143 -1 O LEU A 142 N VAL A 132 SHEET 1 AA2 2 LEU A 262 PRO A 263 0 SHEET 2 AA2 2 VAL A 487 VAL A 488 1 O VAL A 488 N LEU A 262 SHEET 1 AA3 2 THR A 347 GLY A 352 0 SHEET 2 AA3 2 ASP A 355 LEU A 359 -1 O ARG A 357 N TRP A 349 SHEET 1 AA4 5 ASN B 354 ILE B 358 0 SHEET 2 AA4 5 ASN B 394 ARG B 403 -1 O VAL B 395 N ILE B 358 SHEET 3 AA4 5 PRO B 507 GLU B 516 -1 O TYR B 508 N ILE B 402 SHEET 4 AA4 5 GLY B 431 ASN B 437 -1 N ILE B 434 O VAL B 511 SHEET 5 AA4 5 THR B 376 CYS B 379 -1 N LYS B 378 O VAL B 433 SHEET 1 AA5 3 CYS B 361 VAL B 362 0 SHEET 2 AA5 3 VAL B 524 CYS B 525 1 O CYS B 525 N CYS B 361 SHEET 3 AA5 3 CYS B 391 PHE B 392 -1 N PHE B 392 O VAL B 524 SHEET 1 AA6 2 LEU B 452 ARG B 454 0 SHEET 2 AA6 2 LEU B 492 SER B 494 -1 O GLN B 493 N TYR B 453 SHEET 1 AA7 2 TYR B 473 GLN B 474 0 SHEET 2 AA7 2 CYS B 488 TYR B 489 -1 O TYR B 489 N TYR B 473 SSBOND 1 CYS A 133 CYS A 141 1555 1555 2.04 SSBOND 2 CYS A 344 CYS A 361 1555 1555 2.07 SSBOND 3 CYS A 530 CYS A 542 1555 1555 2.05 SSBOND 4 CYS B 336 CYS B 361 1555 1555 2.05 SSBOND 5 CYS B 379 CYS B 432 1555 1555 2.08 SSBOND 6 CYS B 391 CYS B 525 1555 1555 2.08 SSBOND 7 CYS B 480 CYS B 488 1555 1555 2.02 LINK ND2 ASN A 53 C1 NAG A1001 1555 1555 1.45 LINK ND2 ASN A 90 C1 NAG A1002 1555 1555 1.46 LINK ND2 ASN A 103 C1 NAG A1003 1555 1555 1.46 LINK ND2 ASN A 546 C1 NAG A1004 1555 1555 1.44 LINK ND2 ASN B 343 C1 NAG B 601 1555 1555 1.46 CISPEP 1 GLU A 145 PRO A 146 0 5.86 CRYST1 139.578 139.578 156.062 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007164 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007164 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006408 0.00000